dihexa c-met cancer risk Targeting Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications Hepatocyte Growth Factor/c-Met Signaling in
Hepatocyte Growth Factor c Met Signaling in Head and Neck Cancer and Implications for Treatment Global and regional cancer burden attributable to modifiable risk factors to inform prevention IARC Dihexa targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the c MET receptor, it helps cells take in nutrients and rebuildespecially in cases where recovery is slow or Targeting c MET in gastrointestinal tumours: rationale, opportunities and challenges Nature Reviews Clinical Oncology
Pay in 4 interest-free payments of $5.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


